Jardine Matheson is making a powerful move by acquiring Australia’s I-MED for an impressive $2.4 billion enterprise value, dramatically boosting its healthcare portfolio. This bold step marks a strategic leap into the fast-growing world of medical diagnostics, positioning the company at the forefront of industry innovation